The SOPHiA DDM™ Platform enables real-time SARS-CoV-2 surveillance, allowing the detection of new and emerging strains with high accuracy and confidence. Furthermore, as vaccination efforts improve around the globe, the use of SOPHiA DDM™ provides access to new insights for better understanding the variants that “escape” immunity. Join us to explore how you can streamline your workflow to achieve high-quality results for SARS-CoV-2 whole-genome analyses.

During this webinar, our experts will:

-Present how the SOPHiA DDM™ Platform accelerates SARS-CoV-2 analyses with user-friendly features, such as automatic clade and lineage assignment

-Detail the recent guidelines established with international partners for more accurate amplicon-based genotyping of SARS-CoV-2

-Show evidence for a new mutational hotspot, W152

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.